Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000197348 | SCV000616568 | benign | RASopathy | 2017-05-09 | reviewed by expert panel | curation | The filtering allele frequency of the c.846C>T (p.Pro282=) variant in the MAP2K2 gene is 0.515% (46/6886) of Latino chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581) |
Laboratory for Molecular Medicine, |
RCV000039496 | SCV000063185 | benign | not specified | 2010-01-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000197348 | SCV000252872 | benign | RASopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000039496 | SCV000314704 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001000054 | SCV000885673 | benign | Cardiofaciocutaneous syndrome 4 | 2021-11-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705638 | SCV001863023 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813316 | SCV002060582 | benign | Noonan syndrome and Noonan-related syndrome | 2021-05-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444458 | SCV002677591 | benign | Cardiovascular phenotype | 2021-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001705638 | SCV004141448 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MAP2K2: BP4, BP7, BS1 |
Clinical Genetics, |
RCV000039496 | SCV001920492 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001705638 | SCV001958343 | likely benign | not provided | no assertion criteria provided | clinical testing |